Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00875
Full Text
Open PDFAbstract
Available in full text
Date
September 13, 2019
Authors
Publisher
Frontiers Media SA